E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Under the terms of the agreement, Hanmi will receive an upfront payment of USD 190 million from Genentech.
imphoenix82
The ANVISA GMP certification will help Innogen accelerate the registration and commercial launch of Efsubaglutide alfa across all PIC/S-aligned emerging markets, including Hong Kong, Southeast Asia and Latin America.
imphoenix82
The future of obesity care will involve multidisciplinary collaboration between physicians, dieticians, fitness professionals and patient support teams, says Ajanta Pharma.
imphoenix82
Novo Nordisk plans to begin a phase 3 development programme for zenagamtide in adults with type 2 diabetes during the second half of 2026.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
